Your session is about to expire
← Back to Search
Educational Video for Brain Cancer
N/A
Recruiting
Led By Caroline Chung
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
PATIENT ELIGIBILITY CRITERIA: Adult patients with newly diagnosed glioma (World Health Organization [WHO] grade 2-4) who are planned for a 6-week course of radiotherapy after surgery
Be older than 18 years old
Must not have
PATIENT ELIGIBILITY CRITERIA: Poor performance status (Karnofsky performance status [KPS] < 60) that prevent the ability to complete the questionnaires
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from baseline to 2 weeks, 6 weeks, and 1 month post-rt
Awards & highlights
No Placebo-Only Group
Summary
This trial studies a customized video intervention to see if it can reduce anxiety for brain cancer patients undergoing radiation treatment and their caregivers.
Who is the study for?
This trial is for adult patients with newly diagnosed glioma (grades 2-4) who are about to start a 6-week radiotherapy post-surgery and can fill out questionnaires in English. It also includes their adult caregivers who can do the same. Those with significant cognitive or psychiatric issues, or poor performance status (KPS < 60), cannot participate.
What is being tested?
The study tests if a personalized video explaining symptoms and side effects related to the patient's brain tumor can reduce anxiety for both patients and caregivers during radiation treatment, potentially improving quality of life.
What are the potential side effects?
Since this intervention involves educational materials rather than medical treatments, traditional physical side effects are not expected. However, there may be emotional reactions to the content of the videos.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have a newly diagnosed brain tumor and am set for radiotherapy after surgery.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am unable to complete daily tasks without assistance.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from baseline to 2 weeks, 6 weeks, and 1 month post-rt
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline to 2 weeks, 6 weeks, and 1 month post-rt
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Anxiety
Secondary study objectives
Change in patient and caregiver S-Anxiety subscale score of the STAI and Distress Thermometer scores
Anxiety
Changes in patient Distress Thermometer score and FACT-Br score
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Arm I (NIRS)Experimental Treatment4 Interventions
Patients receive standard of care verbal and written education materials. Patients also receive a customized video which includes a description of each of their tumor, functional areas of the brain affected, and possible symptoms from the tumor and radiation treatment based on the neuro-imaging features. Patients and their caregivers watch the video together or separately over 1.5-3 minutes before the end of the first week of radiation treatment. Within 2 weeks after watching the NIRS video, patients complete an optional survey over 5-10 minutes.
Group II: Arm II (standard of care)Active Control2 Interventions
Patients receive standard of care verbal and written education materials.
Find a Location
Who is running the clinical trial?
M.D. Anderson Cancer CenterLead Sponsor
3,067 Previous Clinical Trials
1,802,544 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,928 Previous Clinical Trials
41,017,958 Total Patients Enrolled
Caroline ChungPrincipal InvestigatorM.D. Anderson Cancer Center
4 Previous Clinical Trials
131 Total Patients Enrolled
Media Library
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger